Monographie - Clonidine hydrochloride

Ostatnia aktualizacja :
28/04/2024

Clonidine hydrochloride

Struktura chemiczna

Nazwa handlowa

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Catapres	Australia, Irlandia, Nowa Zelandia, Wielka Brytania
Catapresan	Austria, Finlandia, Grecja, Hiszpania, Holandia, Niemcy, Szwajcaria, Szwecja, Wenezuela, Włochy
Catapressan	Belgia, Francja , Luksemburg, Maroko, Tunisie
Clonidin	Brazylia, Niemcy
Clonidina	Argentyna, Chile, Hiszpania, Wenezuela
Clonipres	Wenezuela
Haemiton	Niemcy
Lowpres	Wenezuela
Paracefan	Niemcy

Bibliografia : Clonidine hydrochloride

	Typ	Publikacja
186	Czasopismo	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
346	Czasopismo	Wulf H, Gleim M, Mignat C. The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes. J Pain Symptom Manage 1994 ; 9: 308-311.
650	Czasopismo	Trissel LA, Hassenbusch SJ. Development of clonidine hydrochloride injections for epidural and intrathecal administration. Int J Pharm Compound 1997 ; 1: 274-277.
1506	Czasopismo	Lopez-Cabezas C, Guerrero L, Molas G, Anglada H, Soy D. Physicochemical compatibility of high concentration drugs usually Y-site administered in intensive care units. EJHP 2015 ;22:107-112.
1508	Czasopismo	Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F. Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU. EJHP 2015 ;22:123-124.
1516	Laboratorium	Ropivacaine (Naropeine®) - Summary of Product Characteristics Mercury Pharmaceuticals Limited 2012
1601	Czasopismo	Godwin DA, Kim NH, Zuniga R. Stability of a baclofen and clonidine hydrochloride admixture for intrathecal administration. Hosp Pharm 2001 ; 36: 950-954.
1665	Czasopismo	Öster Svedberg K, McKenzie J, Larrivee-Elkins C. Compatibility of ropivacaine with morphine, sufentanil, fentanyl, or clonidine. J Clin Pharm Ther 2002 ; 21: 39-45.
1708	Czasopismo	Xu QA, Trissel LA, Pham L. Physical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringes. Int J Pharm Compound 2002 ; 6: 66-69.
1869	Czasopismo	Hildebrand KR, Elsberry DD, Hassenbusch SJ. Stability and compatibility of morphine-clonidine admixtures in an implantable infusion system. J Pain Symptom Manage 2003 ; 25, 5: 464-471.
1928	Czasopismo	Alvarez JC, De Mazancourt Ph, Chartier-Kastler E, Denys P. Drug stability testing to support clinical feasibility investigations for intrathecal baclofen-clonidine admixture. J Pain Symptom Manage 2004 ; 28, 3: 268-272.
1948	Czasopismo	Classen AM, Wimbish GH, Kupiec TC. Stability of admixtures containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system. J Pain Symptom Manage 2004 ; 28, 6: 603-611.
2018	Czasopismo	Veggeland T. Visual compatibility of clonidine with selected drugs. Am J Health-Syst Pharm 2005 ; 62: 1968-1969.
2184	Czasopismo	Vranken JH, van Kan HJM, ven der Vegt MH. Stability and compatibility of a meperidine-clonidine mixture in portable pump reservoirs for the management of cancer pain syndromes. J Pain Symptom Manage 2006 ; 32, 4: 297-299.
2248	Czasopismo	Shields D, Montenegro R. Chemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration. Neuromodulation 2007 ; 10, 1: 6-11.
2305	Czasopismo	Bianchi F, Ginggen A, Tardy Y. Stability and compatibility of drug mixtures in an implantable infusion system. Anaesthesia 2008 63, 9: 972-978.
2317	Czasopismo	Hollenwaeger M, Borquin Challandes I, Fallab L.C, Schaad N, Zelger G. Development and stability testing of a concentrated injectable clonidine solution for intrathecal analgesia. EJHP Science 2009 ; 15, 1: 3-5.
3507	Laboratorium	Chirocaine - Summary of Product Characteristics AbbVie 2013
3705	Czasopismo	Knudsen L, Eisend S, Haake N, Kunze T. Physicochemical compatibility of commonly used analgesics and sedatives in the intensive care medicine. EJHP 2014 ;21:161-166
3728	Czasopismo	Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3823	Czasopismo	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.
4011	Czasopismo	Gersonde F, Eisend S, Haake N, Kunze T. Physicochemical compatibility and emulsion stability of propofol with commonly used analgesics and sedatives in an intensive care unit. EJHP 2016 2016;0:1-11
4130	Czasopismo	Koller AK, Krebs S, Dörje F. Untersuchungen zur Kompatibilität von Clonidin mit häufig eingesetzen Arzneimittel auf Intensivstationen. Pharmaceutics 2021 , 13, 21.
4538	Czasopismo	Campbell A, Petrovski M, Senarathna G, Mukadam ,Strunk T, Batty K. Compatibility of pentoxifylline and parenteral medications. Archives of Disease in Childhood 2020 ; 105: 395-397.
4643	Czasopismo	Catry E, Colsoul M-L, Closset M, Nyssen C, Hubert J, Soumoy L, Bihin B, Jamart J, Hecq J-D, Galanti L. Evaluation of 30-day stability of morphine hydrochloride and clonidine at high and low concentrations in polypropylene syringes. EJHP 2021
4698	Czasopismo	Ayari G, D'Huart E, Vigneron J, Demoré B. Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs. Pharmaceutical Technology in Hospital Pharmacy 2022
4730	Czasopismo	Sorrieul J, Robert J, Vincent L, Andre M, Bourcier B, Bienfait F, Jubier Hamon S, Dupoiron D, Devys C. Stability of Morphine Sulfate-Clonidine and Sufentanil-Clonidine Mixtures. Neuromodulation 2022

Mentions Légales